Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Nov 28, 2013; 19(44): 8034-8041
Published online Nov 28, 2013. doi: 10.3748/wjg.v19.i44.8034
Published online Nov 28, 2013. doi: 10.3748/wjg.v19.i44.8034
Total | Severe CDI | Non-severe CDI | P value | |
n = 40 | n = 15 | n = 25 | ||
Age (yr) | 62.9 (55.3-72.4) | 59.52 (54.8-77.3) | 64.27 (56.1-72.2) | 0.99 |
Male gender | 27 (67.5) | 13 (86.7) | 14 (56.0) | 0.045 |
Origin of patient | 0.61 | |||
Home | 14 (35.0) | 6 (40) | 8 (32) | |
Other ward and/or other hospital | 26 (65.0) | 9 (60) | 17 (68) | |
Diagnosis at MICU admission | 0.39 | |||
Respiratory disease | 15 (37.5) | 3 (20) | 12 (48) | |
Septic shock | 12 (30.0) | 6 (40) | 6 (24) | |
Renal disease | 3 (7.5) | 1 (6.7) | 2 (8) | |
Gastrointestinal disease | 3 (7.5) | 1 (6.7) | 2 (8) | |
Neurological disease | 3 (7.5) | 1 (6.7) | 2 (8) | |
Other | 4 (10.0) | 3 (20) | 1 (4) | |
Clinical symptoms and biological features at diagnosis | ||||
Fever | 23 (57.5) | 8 (53.3) | 15 (60.0) | 0.75 |
Abdominal pain | 15 (37.5) | 7 (46.7) | 8 (32.0) | 0.35 |
Duration of diarrhoea (d) | 13.0 (8.0-19.5) | 18 (5-29) | 13 (8-17) | 0.38 |
C-reactive protein (mg/L) | 117 (60-193) | 185 (73-339) | 105 (39-127) | 0.01 |
Albumin count (g/L) | 26.0 (20.0-28.0) | 23 (17-27) | 26 (21-28) | 0.30 |
Leukocyte count (x 109/L) | 14.4 (9.5-21.7) | 17.9 (10.6-33.4) | 12.4 (9.0-21.1) | 0.17 |
Previous exposure to CDI risk factors within 8 wk before onset of symptoms | ||||
Hospitalisation | 28 (70.0) | 10 (66.7) | 18 (72.0) | 0.72 |
Exposure to PPI | 21 (52.5) | 10 (66.7) | 11 (44.0) | 0.17 |
Chemotherapy | 12 (30) | 5 (33.3) | 7 (28.0) | 0.72 |
Gastrointestinal procedures | 23 (57.5) | 9 (60.0) | 14 (56.0) | 0.80 |
Antibiotic treatment | 38 (95.0) | 15 (100) | 23 (92) | 0.26 |
Cephalosporins 3rd generation | 22 (55) | 8 (53.3) | 14 (56) | 0.87 |
Clindamycin | 2 (5) | 1 (6.7) | 1 (4) | 0.71 |
Coamoxiclav | 16 (40) | 8 (53.3) | 8 (32) | 0.18 |
Fluoroquinolones | 26 (65) | 13 (86.7) | 13 (52) | 0.026 |
Treatment | 0.06 | |||
No treatment | 5 (12.5) | 2 (13.3) | 3 (12.0) | |
Only metronidazole | 25 (62.5) | 6 (40) | 19 (76) | |
Only vancomycin | 2 (5) | 2 (13.3) | 0 (0) | |
Metronidazole+vancomycin | 8 (20) | 5 (33.3) | 3 (12.0) | |
Duration of hospital stay (d) and outcomes | ||||
LOS in hospital | 27.0 (13.5-50.8) | 16 (5-48) | 28.0 (16.0-55.5) | 0.26 |
LOS in MICU | 14.0 (5.0-22.8) | 8 (2-21) | 16.0 (6.0-25.5) | 0.27 |
Death in 30 d | 16 (40) | 9 (60) | 7 (28) | 0.046 |
-
Citation: Khanafer N, Touré A, Chambrier C, Cour M, Reverdy ME, Argaud L, Vanhems P. Predictors of
Clostridium difficile infection severity in patients hospitalised in medical intensive care. World J Gastroenterol 2013; 19(44): 8034-8041 - URL: https://www.wjgnet.com/1007-9327/full/v19/i44/8034.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i44.8034